3-hydroxy-3-methylglutaryl-coenzyme a and Disease Exacerbation

3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adigun, R; Asleh, R; Boilson, BA; Briasoulis, A; Daly, RC; Edwards, BS; Kushwaha, SS; Lerman, A; Maltais, S; Pereira, NL1

Other Studies

1 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Disease Exacerbation

ArticleYear
Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.
    ESC heart failure, 2018, Volume: 5, Issue:6

    Topics: Acyl Coenzyme A; Allografts; Biopsy; Coronary Vessels; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Time Factors; Time-to-Treatment; Ultrasonography, Interventional; Vascular Diseases

2018